TLRY vs WULF · rev $915.5M vs rev $78.8M
Tilray Inc (TLRY) versus Terawulf Inc (WULF) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Terawulf Inc (WULF) is a capital markets company listed on US.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported WULF revenue for 2026-06-30 was $78.8M. Net income was -$1.37B. WULF currently screens at market cap $2.05B.
TLRY currently screens at market cap $573.9M. WULF currently screens at market cap $2.05B.
Not investment advice. Open the TLRY and WULF stock pages for the full models.
Not investment advice.